Identification of the molecular mechanism of insulin-like growth factor-1 (igf-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome

HIGHLIGHTS

• who: Archana Arjunan from the Department of Anatomy, Chonnam National University Medical School, Hwasun, Jeollanamu2011Do, Republic of Korea have published the article: Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome, in the Journal: (JOURNAL)
• what: The authors focus on the potential therapeutic effects of IGF-1 in NDD associated with MetS and the molecular mechanisms underlying its pharmacological effects.

SUMMARY

Metabolic syndrome (MetS) is a collection of metabolic abnormalities, including hypertension, central obesity, and atherogenic . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.